Concord Wealth Partners Atara Biotherapeutics, Inc. Transaction History

Concord Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$4.69 - $9.84 $234 - $492	-50 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$8.44 - $16.89 $50 - $101	6 Added 13.64%	50 $0
Q4 2021 Jan 21, 2022	BUY	$14.7 - $19.89 $646 - $875	44 New	44 $1,000
Q2 2021 Jul 29, 2021	SELL	$12.89 - $16.58 $773 - $994	-60 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.0 - $20.72 $840 - $1,243	60 New	60 $1,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.